Literature DB >> 12711633

Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.

W-S Vanessa Ho1, C Robin Hiley.   

Abstract

1. The nonpsychoactive cannabinoid abnormal-cannabidiol (trans-4-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) (abn-cbd) produced concentration-dependent relaxation of methoxamine-precontracted rat small mesenteric artery. Endothelial removal reduced abn-cbd potency six-fold without affecting the maximum relaxation. 2. In endothelium-intact vessels, abn-cbd was less potent under 60 mM KCl-induced tone and inhibited by combination of L-N(G)-nitroarginine methyl ester (L-NAME) (nitric oxide synthase inhibitor; 300 micro M), apamin (small conductance Ca(2+)-activated K(+) channels inhibitor; 50 nM) and charybdotoxin (inhibitor of intermediate conductance Ca(2+)-activated K(+) channels and large conductance Ca(2+)-activated K(+) channels BK(Ca); 50 nM). L-NAME alone or in combination with either toxin alone had little effect. 3. In intact vessels, relaxations to abn-cbd were inhibited by SR 141716A (cannabinoid receptor antagonist; 1 or 3 micro M). Concomitant addition of L-NAME, apamin and charybdotoxin had no further effect. Other cannabinoid receptor antagonists either had little (SR 144528; 1 micro M and AM 251; 1 micro M) or no effect (AM 630; 10 micro M and AM 281; 1 micro M). Inhibition of gap junctions, G(i/o) protein coupling and protein kinase A also had no effect. 4. Endothelium-independent relaxation to abn-cbd was unaffected by L-NAME, apamin plus charybdotoxin or capsaicin (10 micro M). Abn-cbd inhibited CaCl(2)-induced contractions in vessels with depleted intracellular Ca(2+) stores and stimulated with methoxamine or KCl. This was insensitive to SR 141716A (3 micro M) but greatly reduced in vessels stimulated with ionomycin (Ca(2+) ionophore; 1 micro M). 5. We conclude that abn-cbd relaxes the rat small mesenteric artery by endothelium-dependent activation of K(+) channels via SR 141716A-sensitive pathways, which do not involve CB(1) and CB(2) receptors. It also causes endothelium-independent, SR 141716A-insensitive, relaxation by inhibiting Ca(2+) entry through voltage-gated Ca(2+) channels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711633      PMCID: PMC1573773          DOI: 10.1038/sj.bjp.0705160

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  55 in total

1.  The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism.

Authors:  L De Petrocellis; T Bisogno; M Maccarrone; J B Davis; A Finazzi-Agro; V Di Marzo
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

2.  2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor.

Authors:  S Kagota; Y Yamaguchi; K Nakamura; T Sugiura; K Waku; M Kunitomo
Journal:  Eur J Pharmacol       Date:  2001-03       Impact factor: 4.432

3.  Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.

Authors:  M Glass; C C Felder
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

Review 4.  Endocannabinoids and vascular function.

Authors:  C J Hillard
Journal:  J Pharmacol Exp Ther       Date:  2000-07       Impact factor: 4.030

5.  Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

Authors:  C S Breivogel; G Griffin; V Di Marzo; B R Martin
Journal:  Mol Pharmacol       Date:  2001-07       Impact factor: 4.436

6.  Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

Authors:  Z Járai; J A Wagner; K Varga; K D Lake; D R Compton; B R Martin; A M Zimmer; T I Bonner; N E Buckley; E Mezey; R K Razdan; A Zimmer; G Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

7.  Hyperpolarisation of rat mesenteric endothelial cells by ATP-sensitive K(+) channel openers.

Authors:  R White; C R Hiley
Journal:  Eur J Pharmacol       Date:  2000-06-02       Impact factor: 4.432

8.  Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries.

Authors:  V Ralevic; D A Kendall; M D Randall; P M Zygmunt; P Movahed; E D Högestätt
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

9.  Interaction of cyclic AMP modulating agents with levcromakalim in the relaxation of rat isolated mesenteric artery.

Authors:  R Omar; F E Bottrill; C R Hiley; R White
Journal:  Eur J Pharmacol       Date:  2000-07-28       Impact factor: 4.432

10.  Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.

Authors:  V Di Marzo; C S Breivogel; Q Tao; D T Bridgen; R K Razdan; A M Zimmer; A Zimmer; B R Martin
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

View more
  32 in total

1.  Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors.

Authors:  Sándor Bátkai; Pál Pacher; Zoltán Járai; Jens A Wagner; George Kunos
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-04-01       Impact factor: 4.733

2.  Plant cannabinoids: a neglected pharmacological treasure trove.

Authors:  Raphael Mechoulam
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

3.  The orphan receptor GPR55 is a novel cannabinoid receptor.

Authors:  E Ryberg; N Larsson; S Sjögren; S Hjorth; N-O Hermansson; J Leonova; T Elebring; K Nilsson; T Drmota; P J Greasley
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

4.  GPR55 and the vascular receptors for cannabinoids.

Authors:  C R Hiley; S S Kaup
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

5.  Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product.

Authors:  H Kozłowska; M Baranowska; E Schlicker; M Kozłowski; J Laudañski; B Malinowska
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

6.  Activation of GPR18 by cannabinoid compounds: a tale of biased agonism.

Authors:  Linda Console-Bram; Eugen Brailoiu; Gabriela Cristina Brailoiu; Haleli Sharir; Mary E Abood
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 7.  Endothelial atypical cannabinoid receptor: do we have enough evidence?

Authors:  Alexander I Bondarenko
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

8.  Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.

Authors:  L Moezi; S A Gaskari; H Liu; S K Baik; A R Dehpour; S S Lee
Journal:  Br J Pharmacol       Date:  2006-10-16       Impact factor: 8.739

Review 9.  Receptors for acylethanolamides-GPR55 and GPR119.

Authors:  Grzegorz Godlewski; László Offertáler; Jens A Wagner; George Kunos
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-07-15       Impact factor: 3.072

10.  Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.

Authors:  Sándor Bátkai; Pál Pacher; Douglas Osei-Hyiaman; Svetlana Radaeva; Jie Liu; Judith Harvey-White; László Offertáler; Ken Mackie; M Audrey Rudd; Richard D Bukoski; George Kunos
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.